semaglutide fatty liver disease Gets FDA Greenlight for MASH Pharmacotherapy for Non-alcoholic Fatty Liver

This represents an entirely different mechanistic approach - oral insulin delivery - which could reshape the T2D treatment algorithm if approvals and commercialization succeed

10.1126/science.1218498 102 ShayJ

Carlstrom, K

Experts to discuss AIDING results for automated insulin delivery in the hospital Francisco Pasquel, MD, MPH, and other experts will share findings from this study evaluating automated insulin delivery initiated in the hospital compared with daily injections in people with type 1 or type 2 diabetes

Krka, Slovenia) intraperitoneally), we induced abdominal compartment syndrome as described before and maintained high abdominal pressure at 25 mmHg for 120 min before sacrifice